Clinical Trial

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to see and learn the effect of multiple doses of a strong CYP3A4 inhibitor and a potent UGT2B7 inhibitor on the PK of PF-07220060.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-29; most recent amendment 2026-03-30.
Status change: Recruiting → Completed 2026-03-30
Status change: Not Yet Recruiting → Recruiting 2025-11-22
Trial Details
NCT Number NCT07160738
Lead Sponsor Pfizer
Conditions Healthy Adults
Enrollment 25 participants
Start Date 2025-09-22
Primary Completion 2025-11-24 (estimated)
Study Completion 2025-12-22 (estimated)
Updated on ClinicalTrials.gov 2026-04-03